BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19123337)

  • 1. [Key points for clinical orientation in the secondary development of famous and superior Chinese patent drugs].
    Shang HC; Liu Y; Zhang JH
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Oct; 28(10):939-40. PubMed ID: 19123337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical orientation of post-marketing Chinese patent drugs: an evidence-based practice].
    Shang HC; Zhang BL; Li YP
    Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):887-90. PubMed ID: 18782528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of re-evaluation and development of Chinese herbal drugs].
    Gao Y; Ma Z; Zhang B
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):1-4. PubMed ID: 22741451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Some issues to notice in the research and quality evaluation of external preparations of traditional Chinese medicine].
    Jin F
    Zhongguo Zhong Yao Za Zhi; 2010 Nov; 35(21):2934-6. PubMed ID: 21322963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regional development of patents of traditional Chinese medicine compounds on basis of cluster analysis].
    Yang X; Xiao S
    Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(16):2472-7. PubMed ID: 23234153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cluster analysis on authorized patents of compound traditional Chinese medicines with different efficacy in 2010].
    Yang X; Xiao S; Guo Z
    Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(16):2478-82. PubMed ID: 23234154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Response to US review rules on patent subject matter of traditional Chinese medicine compositions].
    Liu P; Cao YD; Gong RJ; Liu W
    Zhongguo Zhong Yao Za Zhi; 2018 Feb; 43(3):627-630. PubMed ID: 29600632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current quality research situation of precious Chinese patent medicine].
    Lin L; Liu XQ; Xu H
    Zhongguo Zhong Yao Za Zhi; 2008 Feb; 33(3):329-33. PubMed ID: 18536475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Problems in preparation of toxic herbs in process of research and development of new traditional Chinese medicine of rheumatism, orthopedics and surgery].
    Wang T; Zhou G
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(17):2653-5. PubMed ID: 23236771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Using barcode in safety monitoring of traditional Chinese medicines injection].
    Wang ZF; Zhang DZ; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2705-6. PubMed ID: 23285914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction of evaluation systems for traditional Chinese medicine multiple drug delivery system on basis of component level].
    Yu DH; Liu D; Jia XB; Sun E; Zhang ZH; Xiao W
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(17):2667-71. PubMed ID: 23236774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asian medicine. The new face of traditional Chinese medicine.
    Normile D
    Science; 2003 Jan; 299(5604):188-90. PubMed ID: 12522228
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thinking of current situation about decreasing, abolishing and substitution of Chinese medicine species in Shanghanlun].
    Ling Y; Zhou C
    Zhongguo Zhong Yao Za Zhi; 2010 May; 35(9):1209-12. PubMed ID: 20707083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Discussion on establishment of quality control system for intensive hospital monitoring on traditional Chinese medicine injections].
    Jiang JJ; Xie YM
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2689-91. PubMed ID: 23285909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Closed-loop management model of clinical investigational product for new drug of traditional Chinese medicine].
    Wu P; Zhang JW
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(17):2898-900. PubMed ID: 24380320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring].
    Wang D; Du XX
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2686-8. PubMed ID: 23285908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Research on establishment of clinical safety intensive hospital monitoring net of traditional Chinese medicine injection].
    Wang LX; Xie YM; Wang ZF
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2692-4. PubMed ID: 23285910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Some advances and prospects in fingerprintings of traditional Chinese medicines].
    Han Y; Huo F; Yang Y; Liao Y; Liu H
    Se Pu; 2008 Mar; 26(2):142-52. PubMed ID: 18581844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Safety research in Chinese medicines based on application of data mining].
    Tong Y; Yang J; Li C; He W
    Zhongguo Zhong Yao Za Zhi; 2011 Nov; 36(21):3047-50. PubMed ID: 22308699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specificity of traditional Chinese medicine's clinical re-evaluation].
    Li LD; Li YK; Li FJ
    Zhongguo Zhong Yao Za Zhi; 2014 Jan; 39(1):3-4. PubMed ID: 24754158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.